Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ingenol mebutate gel is effective against anogenital warts - a case series in 17 patients
R. E. Schopf
Journal of the European Academy of Dermatology and Venereology (2015) Vol. 30, Iss. 6, pp. 1041-1043
Closed Access | Times Cited: 21

Showing 21 citing articles:

Why Is Wnt/β-Catenin Not Yet Targeted in Routine Cancer Care?
Auriane de Pellegars-Malhortie, Laurence Picque Lasorsa, Thibault Mazard, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 949-949
Open Access | Times Cited: 5
Penile warts: an update on their evaluation and management
Alexander K. C. Leung, Benjamin Barankin, Kin Fon Leong, et al.
Drugs in Context (2018) Vol. 7, pp. 1-14
Open Access | Times Cited: 43
Ingenane Diterpenoids
Giovanni Appendino
Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products (2016), pp. 1-90
Closed Access | Times Cited: 32
Kondylome bei HIV-Infizierten
Ulrike Wieland, Alexander Kreuter
Der Hautarzt (2017) Vol. 68, Iss. 3, pp. 192-198
Closed Access | Times Cited: 15
Ingenol Mebutate Topical Gel A Status Report On Clinical Use Beyond Actinic Keratosis.
Del Rosso Jq
PubMed (2016) Vol. 9, Iss. 11 Suppl 1, pp. S3-S11
Closed Access | Times Cited: 11
Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments
Tamara Gracia‐Cazaña, Salvador González, Yolanda Gilaberte
Actas Dermo-Sifiliográficas (2016) Vol. 107, Iss. 9, pp. 730-739
Open Access | Times Cited: 9
An exploratory, prospective, open‐label trial of ingenol mebutate gel 0.05% for the treatment of external anogenital warts
Helle Kiellberg Larsen, Christina Alette Banzhaf, Simon Francis Thomsen, et al.
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 32, Iss. 5, pp. 825-831
Closed Access | Times Cited: 8
Ingenol mebutate induces a tumor cell-directed inflammatory response and antimicrobial peptides thereby promoting rapid tumor destruction and wound healing
Stephan Alexander Braun, Julia A. Baran, Holger Schrumpf, et al.
European journal of medical research (2018) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Human Papillomavirus Infection
Zsuzsanna Szalai
Harper's Textbook of Pediatric Dermatology (2011)
Closed Access | Times Cited: 6
Successful treatment of condylomata acuminata at the urethral meatus with high-dose ingenol mebutate gel: Report of two cases
Álvaro Martínez‐Doménech, Jorge Magdaleno‐Tapial, Marta García‐Legaz Martínez, et al.
International Journal of STD & AIDS (2019) Vol. 30, Iss. 8, pp. 817-819
Closed Access | Times Cited: 6
Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte I: tratamientos tópicos
Tamara Gracia‐Cazaña, Salvador González, Yolanda Gilaberte
Actas Dermo-Sifiliográficas (2016) Vol. 107, Iss. 9, pp. 730-739
Closed Access | Times Cited: 5
Ingenol mebutate for the treatment of anogenital condylomata acuminata
Jorge Magdaleno‐Tapial, Cristian Valenzuela‐Oñate, Macarena Giácaman‐von der Weth, et al.
Clinical and Experimental Dermatology (2018) Vol. 44, Iss. 6, pp. 687-690
Closed Access | Times Cited: 5
Ingenol Mebutate Gel 0.05% in the Treatment of Anogenital Warts: A Prospective Controlled Trial Comparing It With Topical Podophyllin Solution 25%
Mohammad Shahidi‐Dadras, Zeinab Bizaval, Mahmood Hoormand, et al.
Sexually Transmitted Diseases (2020) Vol. 47, Iss. 5, pp. 338-343
Closed Access | Times Cited: 4
Human Papillomavirus Infection
Yun Tong, Stephen K. Tyring, Zsuzsanna Szalai
Harper's Textbook of Pediatric Dermatology (2019), pp. 588-597
Closed Access | Times Cited: 3
Topical ingenol mebutate is effective against plantar warts in immunocompromised patients
M. Ben M’Rad, Nakhlé Ayoub, Ribal Mehi
JAAD Case Reports (2017) Vol. 4, Iss. 1, pp. 53-54
Open Access | Times Cited: 2
Multipuncture technique with ingenol mebutate in the treatment of a periungual wart
Gerson Dellatorre, Anarosa Barbosa Sprenger
Anais Brasileiros de Dermatologia (2018) Vol. 93, Iss. 5, pp. 768-769
Open Access | Times Cited: 2
Topical ingenol mebutate for viral wart on the ear
In‐Hye Kang, Ki‐Heon Jeong, Mu‐Hyoung Lee, et al.
Dermatologic Therapy (2018) Vol. 31, Iss. 6, pp. e12738-e12738
Open Access | Times Cited: 2
Immunothrombotic Mechanisms Induced by Ingenol Mebutate Lead to Rapid Necrosis and Clearance of Anogenital Warts
Stephan A. Braun, Alexander T. Bauer, Csongor Németh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13377-13377
Open Access | Times Cited: 2
Ingenol mebutate for the management of cryotherapy‐resistant anogenital warts
Mohammad Shahidi‐Dadras, Mahmood Hoormand, Zeinab Bizaval, et al.
Dermatologic Therapy (2020) Vol. 33, Iss. 6
Open Access | Times Cited: 2
Ingenol mebutate: an unconventional treatment proposal
Emi Dika, Sabina Vaccari, Pier ­Alessandro Fanti, et al.
Dermatologic Therapy (2015) Vol. 29, Iss. 1, pp. 72-72
Open Access | Times Cited: 1
An open-label exploratory study evaluating the efficacy and safety of ingenol mebutate gel 0.05% for the treatment of verruca vulgaris
Neal Bhatia
Journal of the American Academy of Dermatology (2018) Vol. 78, Iss. 3, pp. 595-596
Closed Access
Page 1

Scroll to top